Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ACRT about to move to new highs -- Ignore unavailable to you. Want to Upgrade?

To: Andrew Spurlin who wrote (3536)	3/17/1998 6:05:00 AM
From: BRian Dodd	Read Replies (1) \| Respond to of 7054

I have only posted once before on this thread, but I have found it quite entertaining (vice informative), since I bought ACRT about a week ago. I am bullish about the company, but Davef I too ran that Vector Vest deal and read their analysis. Their bottom line recommendation was "sell" (for a variety of reasons). I guess my point is, if anyone wants to be "informative" and be taken seriously, they should share all of the information they encounter, not just the tidbit that supports their own viewpoint. Mr Pink in my opinion is no multimillion dollar hedge fund manager or the next Warren Buffet, or else let's face it, he wouldn't be posting here with the rest of us. However, I do appreciate his contribution in me being able to buy ACRT at 11 1/8. This again is always IMHO. Rgds, BDodd

To: Andrew Spurlin who wrote (3536)	3/17/1998 8:14:00 AM
From: Andrew Q. Viet	Read Replies (1) \| Respond to of 7054

Here is Mr. Pink famous company,AHG, baptized by a Well-known Accounting Firm. Yes,Yes, AHG committed Fraud: Taken from AHG 10K 8 REPORT OF INDEPENDENT AUDITORS Stockholders and Board of Directors Apria Healthcare Group Inc. We have audited the accompanying consolidated balance sheets of Apria Healthcare Group Inc. (formed as a result of the consolidation of Abbey Healthcare GroupIncorporated and Homedco Group, Inc.) as of December 31, 1995 and 1994 and the related consolidated statements of operations, stockholders' equity and cash flows for each of the three years in the period ended December 31, 1995. Our audits also included the financial statement schedule listed in the Index at Item 14 (a). These financial statements are the responsibility of the management of Apria Healthcare Group Inc. Our responsibility is to express an opinion on these financial statements based on our audits. We did not audit the consolidated financial statements of Abbey Healthcare Group Incorporated for the year ended December 31, 1993, which statements reflects total revenues of $278 million. Those statements were audited by other auditors whose report has been furnished to us, and our opinion, insofar as it relates to data included for Abbey Healthcare Group Incorporated, is based solely on the report of the other auditors. We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audits to obtainreasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits and the report of other auditors provide a reasonablebasis for our opinion. In our opinion, based on our audits and the report of other auditors, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Apria Healthcare Group Inc. andsubsidiaries at December 31, 1995 and 1994 and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 1995, in conformity with generally accepted accounting principles. Also, in our opinion, based on our audits and the report of other auditors, the related financial statement schedule referred to above, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein. We also audited the adjustments described in Note 2 that were applied to restate the 1994 and 1993 financial statements. In our opinion, such adjustments are appropriate and have been properly applied. ERNST & YOUNG LLP